Navigation Links
Repliform® Tissue Regeneration Matrix

ProductsRepliform® Tissue Regeneration Matrix
Company Boston Scientific Corporation
Item Repliform® Tissue Regeneration Matrix
Features 
  • Human dermis architecture is a highly complex structure of banded collagen fibers, elastin, proteoglycans and vascular plexus that provides tensile strength, volume, elasticity and durability.
  • A patented process designed to remove cells that are likely targets of the body's immune response.
  • Collagen fibers are banded in omni-directional patterns to provide tensile strength, including resistance to suture pull-through.
  • Human dermis is pliable allowing it to conform to irregular surfaces.
Description The Repliform Tissue Regeneration Matrix is an acellular human dermal allograft that when surgically implanted is intended to function as a template, facilitating the body's fibroblasts to regenerate normal soft tissue rather than scar.
Info Boston Scientific Corporation
Customer Service: (888) 272-1001
Web site: http://www.bostonscientific.com

Related medicine products :

1. Straight Tissue Forceps
2. Bishop-Harmon Straight Tissue Forceps
3. Bishop-Harmon Curved Tissue Forceps
4. Straight Tissue Forceps - Non-Magnetic
5. Programmable Tissue Stainer TST 40, 115V, 60Hz, 100VA
6. Programmable Tissue Stainer TST 40, 230V, 50Hz, 100VA
7. Tissue-Tek DRS 2000
8. Micro Tissue Forceps
9. Micro Tissue Forceps with round handle
10. LICOX Brain Tissue Oxygen Monitoring System
11. Tissue Forceps (Bishop-Harmon)
The Snellen chart is the default optotype with the standard order of letters (T Z V E C L) as default. When the Refresh 'R' button is pressed, the letters ( or pictures ) are replaced with a random s...
Snellen 20' Eye Test Chart....
... High-level accuracy from the finest ... Easy to use. The Paradigm ... printer, extending its versatility. Effective ... Analyzer is designed to measure ...
... Optics can be useful in the treatment ... while normalizing blood sugar. Post cataract surgery ... magnification. Accommodative esotropia - address residual near ... Sunglasses - add bifocals. Specialty - add ...
Medicine Products:
(Date:4/30/2016)... , ... April 30, 2016 ... ... CBC News on April 4th, 2016 questioned the use of the HyProCure ... EOTTS-HyProCure as “a controversial procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, ...
(Date:4/29/2016)... ... April 29, 2016 , ... In an article published April ... enthusiasm for Botox and lip injections, which she underwent in order to feel more ... Music and Arts Festival. The article explains that Ms. Mirmelli’s situation is not unique; ...
(Date:4/29/2016)... Georgia (PRWEB) , ... April 29, 2016 , ... On ... rural hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB ... Rep. Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and ...
(Date:4/29/2016)... ... 29, 2016 , ... Coast Dental Fort Stewart is celebrating its grand opening ... the Exchange Furniture Mall at 112 Vilseck Road in Fort Stewart. There will be ... attendees will have the opportunity to meet general dentists Thomas Richards, DDS, and Josh ...
(Date:4/29/2016)... ... April 29, 2016 , ... World ... the Gyrociser, an exercise invention which aids in proper muscle development. , "The ... CEO and Creative Director of World Patent Marketing. "Globalization has threatened the future ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... of oral drug delivery systems, announced today that the Company ... Joseph Gunnar & Co. LLC, taking place on ... Nadav Kidron , CEO of Oramed, will present a ...   PIONEERS 2016, presented by Joseph Gunnar ...
(Date:4/28/2016)... , April 28, 2016 ... development of innovative peptide and gene-based immunotherapeutics and vaccines for ... will be presenting at the 3rd Annual Growth Capital ... 5 th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... am on Wednesday, May 4 th by Dr. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 ... Sachs CEO Forums in Zürich gab Strekin ... führenden Wirkstoffkandidaten STR001 zur Erhaltung des Resthörvermögens ... wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie mit ... Frankreich angeworben. STR001 wird während der Operation ...
Breaking Medicine Technology: